Accellta
Singles - Breakthrough Development Enabling
FromAccellta
Singles™ is a breakthrough development enabling efficient culturing of human stem cells as single-cells in suspension. The cells grown using the Singles™ technology are uniform, undifferentiated, self-renewable, and form single or duplicate cells in suspension.
Most popular related searches
- Concentration: >40 million cells/ml
- Expansion factor: X50-100 fold in 7 days
- Suitable for human pluripotent stem cells and progenitor cells
- Better control of induced differentiation in suspension
- Platform for genetic modification
- High cloning efficiency
- High recovery rates from freeze-thaw cycles
- Does not require enzymatic splitting
- Rock inhibitor-free, xeno-free defined medium
- Methods for directed differentiation in suspension
- Karyotype stability
- High viability rate
